These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29635655)

  • 1. Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study.
    Skeith L; Abou-Nassar KE; Walker M; Ramsay T; Booth R; Wen SW; Smith GN; Rodger MA
    Am J Perinatol; 2018 Sep; 35(11):1093-1099. PubMed ID: 29635655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort.
    Chaudhry SH; Taljaard M; MacFarlane AJ; Gaudet LM; Smith GN; Rodger M; Rennicks White R; Walker MC; Wen SW
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):75. PubMed ID: 30782144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile.
    Högdén A; Antovic A; Berg E; Bremme K; Chaireti R
    Lupus; 2019 Jun; 28(7):868-877. PubMed ID: 31132916
    [No Abstract]   [Full Text] [Related]  

  • 5. The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta-analysis.
    Xu J; Chen D; Duan X; Li L; Tang Y; Peng B
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1523-1533. PubMed ID: 31131876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland].
    Skrzypczak J; Rajewski M; Wirstlein P; Goździewicz T; Zimmer M; Wołczyński S; Leszczyńska-Gorzelak B; Breborowicz G; Ludwikowski G
    Ginekol Pol; 2011 Oct; 82(10):749-54. PubMed ID: 22379938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome.
    Oron G; Ben-Haroush A; Goldfarb R; Molad Y; Hod M; Bar J
    J Matern Fetal Neonatal Med; 2011 Apr; 24(4):606-9. PubMed ID: 20874430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.
    Bouvier S; Cochery-Nouvellon E; Lavigne-Lissalde G; Mercier E; Marchetti T; Balducchi JP; Marès P; Gris JC
    Blood; 2014 Jan; 123(3):404-13. PubMed ID: 24200687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies.
    Spinillo A; Bellingeri C; Cavagnoli C; Maggio I; Riceputi G; Ruspini B; Cesari S; Beneventi F
    Rheumatology (Oxford); 2021 Mar; 60(3):1148-1157. PubMed ID: 32864694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Shorter Height with Increased Risk of Ischaemic Placental Disease.
    Ogawa K; Morisaki N; Saito S; Sato S; Fujiwara T; Sago H
    Paediatr Perinat Epidemiol; 2017 May; 31(3):198-205. PubMed ID: 28317131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions.
    Ulcová-Gallová Z; Bouse V; Krizanovská K; Balvín M; Rokyta Z; Netrvalová L
    Int J Fertil Womens Med; 2001; 46(6):304-8. PubMed ID: 11795690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.
    Fickentscher C; Magorivska I; Janko C; Biermann M; Bilyy R; Nalli C; Tincani A; Medeghini V; Meini A; Nimmerjahn F; Schett G; Muñoz LE; Andreoli L; Herrmann M
    J Immunol Res; 2015; 2015():638129. PubMed ID: 26185769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.